EROSIVE ESOPHAGITIS
Clinical trials for EROSIVE ESOPHAGITIS explained in plain language.
Never miss a new study
Get alerted when new EROSIVE ESOPHAGITIS trials appear
Sign up with your email to follow new studies for EROSIVE ESOPHAGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new pill prevent esophageal damage from returning?
Disease control Not yet recruitingThis trial tests whether an experimental drug called JP-1366 can prevent the return of erosive esophagitis in people whose condition has already healed. About 384 adults aged 19 to 75 will take either JP-1366 or the standard drug lansoprazole daily for 24 weeks. The goal is to se…
Matched conditions: EROSIVE ESOPHAGITIS
Phase: PHASE3 • Sponsor: Onconic Therapeutics Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Smart bottle cap could reveal hidden missed doses in GERD patients
Disease control Not yet recruitingThis study tests whether a digital bottle cap called FORTISKAP™ can detect missed doses of proton pump inhibitors (PPIs) in people with GERD more accurately than standard methods like pharmacy fill records or patient questionnaires. Fifty adults with GERD who take a daily PPI wil…
Matched conditions: EROSIVE ESOPHAGITIS
Phase: NA • Sponsor: Cosmos Rx, Inc • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC